Sales & Marketing

With opportunity and risk lurking in equal measure, today’s key considerations for biopharma startups when building their leadership teams and product go-to-market strategies are outlined.

Content generation on pharma companies social media channels started with sharing links to recent publications and conference presentations. But what is the next step? How can the industry evolve from data dissemination to true two-way engagement?

Simpson Healthcare becomes a Certified B Corporation.

CrowdPharm partners with consumer agency Bernstein-Rein to expand capabilities.

Omnichannel marketing touts delivering efforts across all channels simultaneously, and looks to dethrone the incumbent multichannel marketing, but making the switch isn't exactly easy.

Computer-based simulations are a great approach to pharmaceutical sales training because they are engaging, realistic and help develop critical skills for a data-driven world, writes Jeremy Lovelace.

Global best-in-class data and technology with real-time optimization provides deeper, actionable insights.

The emergence of organized customers demands investment in advanced solutions and next-generation key account management.

Choosing the right team and implementing structure headline necessities for launch.

Promotion signals Health Practice transformation and will impact agency-wide growth.

Cherie Davies, SVP, Executive Creative Director at FCB Chicago, talks about inspiring award-winning creative, especially in COVID times.

Closing the gap between promise and progress.

Grünenthal‘s Florent Edouard talks about AI‘s “key role in the future of marketing.”

The overall gold winners from each of the 19 specialized categories will be revealed on September 9, 2021.

Industry leader set to oversee all aspects of Ogilvy’s Health business.

Key opinion leaders may not be hard to find, but they are very hard to engage because everybody wants a piece of them.

Growing pains of overwhelming, uncoordinated channel use and promotional waste are forcing marketers to explore omnichannel marketing to enable simultaneous orchestration across channels and multiple stakeholders.

Understanding of human behavior can aid in avoiding pitfalls during launch.

Patient centricity and access highlight keys to success for new development.

Harvard Business School Professor Joseph B. Fuller talks about the future prospects for pharma sales forces as they face more restrictions on accessing their target physicians and looming concerns of automation.

Pandemic-reinforced principles of successful drug launch.

In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.

Coordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.

How far should your digital strategy reach? Daniel King and Simon Davies offer five signs that indicate you need better digital support.

Now regulatory review teams have found a way to accelerate their processes — processes not particularly suited to speed — without compromising quality, accuracy, or adherence to regulations, how can this pace be maintained as we emerge from the pandemic?

Storytelling can be used very effectively to communicate with medical professionals without compromising the science, writes Stacey Rivkin.

COVID-19 has been game-changing for pharma sales, driving demand for new models and reps with the right competencies and skills to succeed in a hybrid sales environment.

Evolving preferences of HCPs during the pandemic have put an emphasis on learning new skillsets for pharma reps.

at some point, we won’t be seeing wall-to-wall COVID coverage anymore, but stories about the fallout. How can pharmaceutical brands prepare for what’s next?

Audio platforms provide new opportunities for pharma.